首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I‐PRESERVE) trial
Authors:Pardeep S. Jhund  Inder S. Anand  Michel Komajda  Robert S. McKelvie  Michael R. Zile  Peter E. Carson  John J.V. McMurray
Affiliation:1. Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK;2. Division of Cardiology, University of Minnesota, Minneapolis, MN, USA;3. Université Paris 6 and Hospital Pitié‐Salpétrière, Paris, France;4. Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada;5. Ralph H. Johnsons Veterans Affairs Medical Center and, Medical University of South Carolina, Charleston, SC, USA;6. Georgetown University and Washington DC Veterans Affairs Medical Center, Washington, DC, USA
Abstract:
Keywords:Clinical trial  Heart failure  Preserved ejection fraction  Irbesartan
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号